4-HIPA,
4-hydroxy-iso-phthalate,
4-hydroxy-isophthalate,
4-hydroxyisophthalic acid,
4-Hydroxyisophthalic acid,
636-46-4,
Eupirina,
4-Hydroxy-m-phthalic acid,
4-Hydroxybenzene-1,3-dicarboxylic acid,
Isophthalic acid, 4-hydroxy-,
4-HIPA,
NSC 2445,
4-HYDROXY-1,3-BENZENEDICARBOXYLIC ACID,
UNII-P87FF77O00,
1,3-Benzenedicarboxylic acid, 4-hydroxy-,
EINECS 211-258-0,
4-Hydroxy Isophthalic Acid,
BRN 2211981,
AI3-24050,
P87FF77O00,
4-hydroxyisophthalate,
4-Hydroxy-1,3-benzenedecarboxylic acid,
PubChem15046,
AC1L1ZPI,
4-Hydroxyisophthalic acid;,
4-10-00-02091 (Beilstein Handbook Reference),
SCHEMBL330378,
Acetylsalicylic Acid Impurity B,
ACMC-1B614,
4-Hydroxyisophthalic acid, 95%,
CTK2F4767,
NSC2445,
BCEQKAQCUWUNML-UHFFFAOYSA-N,
ZINC409242,
4-Hydroxy-1,3-benzenedicarboxylate,
CS-M1087,
KS-000010ZT,
NSC-2445,
ANW-34694,
BBL103288,
CH-191,
KM0767,
MFCD00010391,
RW3414,
SBB064147,
STL557098,
4-Hydroxyisophthalic acid, AldrichCPR,
AKOS000121471,
MCULE-1659406510,
QC-2201,
VZ29218,
1,3-Benzenedicarboxylicacid, 4-hydroxy-,
AC-28654,
AJ-22694,
AN-46994,
AS-19417,
BC206996,
LS-85243,
SC-43914,
SY051837,
AB0033939,
DB-054516,
RT-001695,
TL8004451,
FT-0084756,
FT-0618715,
ST50825180,
X8014,
MFCD00010391 (98%),
A21110,
C21168,
1,3-Benzenedicarboxylic acid, 4-hydroxy- (9CI),
W-203364,
Salicylic acid impurity B, European Pharmacopoeia (EP) Reference Standard,
Salicylic acid Related Compound B, United States Pharmacopeia (USP) Reference Standard,
4-Hydroxyisophthalic acid (Salicylic Acid Related Compound B)(Salicylic Acid Impurity B), Pharmaceutical Secondary Standard; Certified Reference Material,
InChI=1/C8H6O5/c9-6-2-1-4(7(10)11)3-5(6)8(12)13/h1-3,9H,(H,10,11)(H,12,13,
Aspirin Impurity B,
1, 4-hydroxy-,
4-Hydroxyisophthalicacid,
4-hydroxyisophtalic acid,
4-Hydroylisophthalic acid,
C8H6O5,
C8-H6-O5,
CID12490,
ACN-001513,
CS-O-31086,
H0257,
4-Hydroxyisophthalic acid, 98% - 25G 25g,